Skip to content

POST OP ANALGESIA IN CESAREAN SECTION

A COMPARATIVE STUDY OF DEXMEDETOMIDINE AS ADJUVANT FOR BUPIVACAINE IN ULTRASOUND GUIDED ERECTOR SPINAE PLANE BLOCK FOR CESAREAN SECTION -A PROSPECTIVE RANDOMIZED CONTROLLED , DOUBLE BLIND STUDY. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054045
Enrollment
50
Registered
2023-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O908- Other complications of the puerperium, not elsewhere classified

Interventions

Sponsors

Dr Benita Abraham
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Undergoing cesarean section

Exclusion criteria

Exclusion criteria: Patient refusal to ESPB presence of coagulopathy or bleeding disorder bradycardia cardiac conduction block were administered ß-adrenergic antagonist or an antiplatelet agent local infection at the injection site hypersensitivity to local amide anesthetics or were hypersensitive or allergic to dexmedetomidine central neuropathy a body mass index >35 kg/m2 uncontrolled diabetes mellitus significant cardiopulmonary disease, hepatic or renal failure or psychiatric disease. Inability to give consent to the study

Design outcomes

Primary

MeasureTime frame
Total analgesic consumption in the first 24 hours after surgeryTimepoint: Total analgesic consumption in the first 24 hours after surgery

Secondary

MeasureTime frame
Incidence of bradycardiaTimepoint: Number;Incidence of hypotensionTimepoint: Number;Incidence of post operative nausea & vomittingTimepoint: Number;Time for first request to analgesiaTimepoint: Hours;Visual analog scale (VAS) for painTimepoint: 0 hour, 2 hours , 4hours, 6 hours , 8 hours, 12hours 24 hours & 48 hours

Countries

India

Contacts

Public ContactDr Rajesh Kumar Kodali

Sri Ramachandra institute of higher education and research

vrajesh.kodali@gmail.com9962398266

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026